Dilution profile // every instrument, one screen, from SEC filings

Rein Therapeutics, Inc. (RNTX)

CIK 1420565 · all EDGAR filings →

Overall dilution risk
HIGHworst of 3 computed signals (offering ability)
= the worst band among the computed sub-ratings, no hidden weighting
not every sub-rating was computable; treat as a floor
Offering ability
HIGH$73.6M registered
= total registered offering amount from the fee exhibits of live registrations (bands: $1M / $20M)
one or more live registrations had no structured fee data, so the true total is AT LEAST this
Overhead supply
NOT COMPUTEDno warrant count tagged in XBRL
= warrant shares outstanding divided by current shares outstanding
absence of a tag is not proof of absence of warrants
Historical dilution
HIGH+1784% O/S in 3y
= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative
a reverse-split-sized cliff is in this window; read the chart
Cash need
HIGH~2.8 months of runway
= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)
the company itself flagged going-concern doubt

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

2021-03-192026-05-13

Latest: 85.5M shares as of May 13, 2026 (10-Q). Share count fell from 90.8M to 4.5M between Oct 28, 2022 and Mar 16, 2023, a pattern consistent with a reverse split (roughly 1-for-20); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.

Cash runway

Going-concern warning

auditor flagged substantial doubt

The company itself flagged going-concern doubt in a filing.

Full breakdown: cash runway tool · source filing →

Warrants

TrancheWarrantsExercise priceTermNotes
Two Thousand Twenty Three Warrantsnot tagged$4.89
Two Thousand Twenty Four Warrantsnot tagged$4.68
Exchange Pre-Funded Warrantsnot tagged$0.001
Bios Pre-Funded Warrantsnot tagged$0.001
Pre Funded Warrantsnot tagged$0.001

Tranches exactly as the company dimensioned them in its 10-Q filed May 15, 2026. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.

No warrant figures tagged in this filer’s XBRL facts. That means the company has not reported them in structured form; it does not prove no warrants exist. The exhibits are the ground truth.

Convertible notes

No convertible-note facts tagged in the 10-Q filed May 15, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.

Registrations and offerings

Registered offering capacity on live registrations: $73.6Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted

S-1Apr 28, 2026$60.1M registeredfiling →
S-1Sep 3, 2025$13.5M registeredfiling →
S-3May 16, 2025no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →

Last 12 months: 5 executed · 2 registered.

EXECUTEDMay 4, 2026Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5
EFFECTIVEApr 30, 2026SEC declared a registration effective — selling can beginEFFECT
REGISTEREDApr 28, 2026S-1 registration — capacity to sell shares, not a sale yetS-1
EXECUTEDMar 2, 2026Unregistered share sale disclosed (8-K item 3.02)8-K
EXECUTEDJan 16, 2026Unregistered share sale disclosed (8-K item 3.02)8-K
EXECUTEDOct 24, 2025Unregistered share sale disclosed (8-K item 3.02)8-K
EXECUTEDSep 9, 2025Unregistered share sale disclosed (8-K item 3.02)8-K
EFFECTIVESep 5, 2025SEC declared a registration effective — selling can beginEFFECT
REGISTEREDSep 3, 2025S-1 registration — capacity to sell shares, not a sale yetS-1
EXECUTEDJul 30, 2025Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5
EXECUTEDJul 30, 2025Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5
EXECUTEDJul 30, 2025Unregistered share sale disclosed (8-K item 3.02)8-K

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full RNTX workspace